Position
CIM, LLC in Corcept Therapeutics Inc
Back to the book · All holders of CORT
Estimated mark uses implied 13F prices (value ÷ shares). Adds are treated as happening at this quarter’s mark; cuts at last quarter’s. Share jumps can be splits, not buys. This is not realized P&L.
Latest estimated mark $36.4K$34.80 → $40.31
| Quarter | Shares | Value | Implied px | Est. mark | Flow | Weight |
|---|---|---|---|---|---|---|
| Q4 2025 | 6.6K | $229.7K | — | — | — | 0.0% |
| Q1 2026 | 6.6K | $266K | $40.31 | $36.4K | −$0 | 0.0% |